CVE-2009-1279

Description

Multiple cross-site scripting (XSS) vulnerabilities in Joomla! 1.5 through 1.5.9 allow remote attackers to inject arbitrary web script or HTML via unspecified vectors to the (1) com_admin component, (2) com_search component when "Gather Search Statistics" is enabled, and (3) the category view in the com_content component.

Category

2.6
CVSS
Severity: Low
CVSS 2.0 •
EPSS 0.01%
Vendor Advisory joomla.org Vendor Advisory joomla.org Vendor Advisory secunia.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://www.securityfocus.com/bid/34360 vdb entry patch
http://developer.joomla.org/security/news/294-20090302-core-comcontent-xss.html vendor advisory
http://secunia.com/advisories/34551 third party advisory vendor advisory
http://developer.joomla.org/security/news/293-20090301-core-multiple-xsscsrf.html vendor advisory
https://exchange.xforce.ibmcloud.com/vulnerabilities/49655 vdb entry
https://exchange.xforce.ibmcloud.com/vulnerabilities/49654 vdb entry

Frequently Asked Questions

What is the severity of CVE-2009-1279?
CVE-2009-1279 has been scored as a low severity vulnerability.
How to fix CVE-2009-1279?
To fix CVE-2009-1279, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2009-1279 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2009-1279 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.